A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2453342
The invention relates to a stable liquid pharmaceutical formulation comprising Cetuximab® and a chimeric monoclonal antibody against the endothelial growth factor receptor (EGF receptor). The formulation has an improved shelf- life and can be used parenterally for treatment of tumours.
L'invention concerne une formulation pharmaceutique liquide stable contenant le Cetuximab®, un anticorps monoclonal chimaire dirigé contre le récepteur du facteur de croissance endothélial (récepteur de EGF). Cette formulation a une grande stabilité au stockage et peut servir au traitement parentéral de tumeurs.
Bachmann Christiane
Haas Udo
Mahler Hanns-Christian
Martini-Marr Ulrike
Mueller Robert
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Liquid formulation comprising cetuximab and a fatty acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid formulation comprising cetuximab and a fatty acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid formulation comprising cetuximab and a fatty acid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1794500